Bioshares Biotechnology Clinical Trials Fund ETF Forecast

Buy or Hold candidate since Aug 12, 2025 Gain 51.10%

The BioShares Biotechnology Clinical Trials ETF price gained 1.62% on the last trading day (Monday, 17th Nov 2025), rising from $32.34 to $32.87. During the last trading day the ETF fluctuated 2.41% from a day low at $32.53 to a day high of $33.32. The price has been going up and down for this period, and there has been a 6.15% gain for the last 2 weeks. Volume fell on the last day by -21 thousand shares and in total, 12 thousand shares were bought and sold for approximately $384.32 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The ETF lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 49.11% during the next 3 months and, with a 90% probability hold a price between $45.88 and $51.48 at the end of this 3-month period.

BBC Signals & Forecast

The BioShares Biotechnology Clinical Trials ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $31.65 and $30.34. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, November 07, 2025, and so far it has risen 10.66%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for BioShares Biotechnology Clinical Trials ETF

BioShares Biotechnology Clinical Trials finds support from accumulated volume at $31.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the ETF moved $0.785 between high and low, or 2.41%. For the last week the ETF has had daily average volatility of 3.16%.

Our recommended stop-loss: $31.74 (-3.42%) (This ETF has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (BBC) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect BioShares Biotechnology Clinical Trials Fund to open at $32.90, and during the day (based on 14 day Average True Range), to move between $32.42 and $33.31, which gives a possible trading interval of +/-$0.89 (+/-2.74%) up or down from last closing price. If BioShares Biotechnology Clinical Trials Fund takes out the full calculated possible swing range there will be an estimated 2.74% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $31.39, some $1.48 (4.49%) from the current price of $32.87, our system finds the risk reward attractive.

Is BioShares Biotechnology Clinical Trials Fund ETF A Buy?

BioShares Biotechnology Clinical Trials holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 6.398 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $32.90 ( 0.117%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk